Search Results - "Jorgenson, James A"

Refine Results
  1. 1
  2. 2

    Using a closed-system protective device to reduce personnel exposure to antineoplastic agents by Wick, C, Slawson, MH, Jorgenson, JA, Tyler, LS

    Published in American journal of health-system pharmacy (15-11-2003)
    “…Surface contamination with and personnel exposure to antineoplastic agents before and after the implementation of a closed-system protective device were…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Budget impact analysis of insulin therapies and associated delivery systems by Lee, Lauren J, Smolen, Lee J, Klein, Timothy M, Foster, Shonda A, Whiteman, Doug, Jorgenson, James A, Hultgren, Steve

    Published in American journal of health-system pharmacy (01-06-2012)
    “…A budget impact analysis of insulin therapies and associated delivery systems is presented. Based on inputted procurement totals, per-item costs (based on 2011…”
    Get full text
    Journal Article
  4. 4

    Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussion by Brooks, Benjamin Rix, Jorgenson, James A, Newhouse, Barbara J, Shefner, Jeremy M, Agnese, Wendy

    Published in The American journal of managed care (01-04-2018)
    “…Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuromuscular disease affecting approximately 5 out of every 100,000 individuals living in the…”
    Get full text
    Journal Article
  5. 5

    Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients by Gilreath, Jeffrey A, Sageser, Daniel S, Jorgenson, James A, Rodgers, George M

    “…Erythropoietic-stimulating agent (ESA) therapy has significantly impacted the management of chemotherapy-induced anemia (CIA) by decreasing the number of red…”
    Get more information
    Journal Article
  6. 6

    Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device by Sessink, Paul JM, Connor, Thomas H, Jorgenson, James A, Tyler, Timothy G

    Published in Journal of oncology pharmacy practice (01-03-2011)
    “…Purpose. Surface contamination with the antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil was compared in 22 US hospital pharmacies…”
    Get full text
    Journal Article
  7. 7

    Benefit of Ribose in a Patient with Fibromyalgia by Gebhart, Benjamin, Jorgenson, James A.

    Published in Pharmacotherapy (01-11-2004)
    “…Ribose was added to the existing treatment regimen of a woman with fibromyalgia, resulting in a decrease in symptoms. It has been postulated that patients with…”
    Get full text
    Journal Article
  8. 8

    Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs by Jorgenson, James A., Spivey, Susan M., Au, Cam, Canann, David, Ritter, Howard, Smith, Bart

    Published in Hospital pharmacy (Philadelphia) (01-09-2008)
    “…Purpose Heightened awareness of hazardous drug contamination in the workplace has increased the number of marketed, closed-system drug transfer devices…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Continued Challenges with the Use of Erythropoiesis-Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy-Guided Health Care by Arbuckle, Rebecca B., Griffith, Niesha L., Iacovelli, Lew M., Johnson, Philip E., Jorgenson, James A., Kloth, Dwight D., Lucarelli, Charles D., Muller, Raymond J.

    Published in Pharmacotherapy (01-05-2008)
    “…Erythropoiesis‐stimulating agents (ESAs) are approved as an alternative to blood transfusions for treating anemia secondary to chemotherapy in patients with…”
    Get full text
    Journal Article
  11. 11

    Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices by Brixner, Diana I, Oderda, Gary M, Nickman, Nancy A, Beveridge, Roy, Jorgenson, James A

    “…Significant changes in Medicare reimbursement for outpatient oncology services were proposed as part of the Medicare Modernization Act of 2003. The purpose of…”
    Get more information
    Journal Article
  12. 12

    International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets by Otsuka, Makoto, Tomita, Hisako, Otsuka, Kuniko, Kamae, Isao, Jorgenson, James A

    “…Ibuprofen tablets on the market in Japan and the USA were compared by manual- and automatic-dissolution tests according to USP24 criteria. Dissolution test…”
    Get more information
    Journal Article
  13. 13

    Components of Medicare reimbursement by Malatestinic, William, Braun, LeeAnn, Jorgenson, James A, Eskew, Jim

    Published in American journal of health-system pharmacy (01-11-2003)
    “…The history of the Medicare reimbursement system, how it works, and issues related to fraud and abuse are discussed. The statutory charge of Medicare is to…”
    Get full text
    Journal Article
  14. 14

    Building a business case for an outpatient pharmacy by Burger, Gregory S, Jorgenson, James A, Stevenson, James G

    Published in Healthcare financial management (01-06-2015)
    “…To be successful, an outpatient prescription pharmacy service built and operated by a hospital should be run as a competitive business, not in the manner of an…”
    Get more information
    Journal Article
  15. 15

    Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device by Nyman, Heather A., Jorgenson, James A., Slawson, Matthew H.

    Published in Hospital pharmacy (Philadelphia) (01-03-2007)
    “…Objective To determine levels of environmental chemotherapy contamination in a new cancer hospital that has exclusively used a closed-system drug transfer…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Development and Implementation of a Pharmacy Directed Community Health Education and Screening Program by Strain, Joey D., Jorgenson, James A., Martin, Sandi

    Published in Hospital pharmacy (Philadelphia) (01-01-2005)
    “…Purpose A major obstacle to successfully offering health care education programs is a lack of access to large numbers of people. To capture a large audience we…”
    Get full text
    Journal Article